VIRSTI THERAPEUTICS
VIRSTI THERAPEUTICS
Industry:
Health Care Medical Oncology Therapeutics
Founded:
2021-01-01
Address:
Stanford, California, United States
Country:
United States
Status:
Closed
Contact:
650-804-2133
Total Funding:
1.35 M USD
Similar Organizations
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Advisors List
More informations about "Virsti Therapeutics"
Virsti Therapeutics - Crunchbase Company Profile & Funding
Virsti Therapeutics is a start-up in the immune-oncology space. Where is Virsti Therapeutics's headquarters? Virsti Therapeutics is located in Stanford, California, United States. How much …See details»
Virsti Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Virsti Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Virsti Therapeutics - Funding, Financials, Valuation & Investors
Virsti Therapeutics is a start-up in the immune-oncology space.See details»
Virsti Therapeutics - Crunchbase
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities. Verismo Therapeutics develops novel chimeric antigen …See details»
Virsti Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
It provides complete and integrated R&D intelligence through artificial intelligence technologies such as natural language processing and machine learning. It empowers global …See details»
VIRSTI THERAPEUTICS, INC. | California Companies Directory
Provide information about VIRSTI THERAPEUTICS, INC., includes incorporation date, status, type, directors, address, contacts information & more.See details»
Virsti Therapeutics, Inc. in Stanford CA - Company Profile
View company leaders and background information for Virsti Therapeutics, Inc. Search our database of over 100 million company and executive profiles.See details»
Virsti Therapeutics, Inc. - fund raising filing
Virsti Therapeutics, Inc. - Most recent fund raising on April 16, 2021 raised Unknown in EquitySee details»
Red Tree Venture Capital Announces Closing of $272 Million …
Oct 6, 2022 · Led by an Accomplished Team with More than 60 years of Combined Experience Investing in, Founding and Operating Life Science Companies Across Various Stages, Sectors …See details»
Red Tree Venture Capital Announces Closing of $272 Million
Jun 10, 2022 · Virsti Therapeutics: Developing unique tumor-targeted peptide conjugates that selectively kill tumor cells or stimulate the immune system to attack cancer. The investment …See details»
FORM D - SEC.gov
Apr 15, 2021 · Virsti Therapeutics, Inc. Jurisdiction of Incorporation/Organization; DELAWARE: Year of Incorporation/OrganizationSee details»
Virsti Therapeutics - Contacts, Employees, Board Members
Virsti Therapeutics is a start-up in the immune-oncology space.See details»
Virsti Therapeutics | CipherBio
Explore Virsti Therapeutics's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Virsti Therapeutics | Evaluate
The latest news, comment and analysis about Virsti Therapeutics from the Vantage editorial team.See details»
The world’s first CRISPR therapy is approved: who will receive it?
Nov 21, 2023 · Casgevy (exagamglogene autotemcel) is a first-of-its-kind treatment made by Vertex Pharmaceuticals and CRISPR Therapeutics in Zug, Switzerland. It comes just 11 years …See details»
“Solidarity” clinical trial for COVID-19 treatments
Solidarity: an unprecedented, international collaboration to identify life-saving treatments for COVID-19. This large, global randomized control trial is designed to provide robust results on …See details»
VISTA: A Mediator of Quiescence and a Promising Target in Cancer ...
V-domain Ig suppressor of T cell activation (VISTA) is a B7 family member that maintains T cell and myeloid quiescence and is a promising target for combina-tion cancer immunotherapy. …See details»
Virsti Therapeutics - Updates, News, Events, Signals & Triggers
Virsti Therapeutics is a start-up in the immune-oncology space. Edit Recent News & Activity SectionSee details»
Wait for galactosemia therapy goes on after FDA shuns Applied ...
7 hours ago · Applied Therapeutics points to the “rapid and sustained reductions in galactitol” produced by the govorestat in paediatric clinical trials. In the Phase III registrational ACTION …See details»
Solidarity Therapeutics Trial produces conclusive evidence on the ...
Oct 15, 2020 · Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and …See details»